Almee™ (an investigational medical device in clinical development) is a treatment program aiming to reduce the psychological impact Pulmonary Fibrosis may have on your life. COMPANION is recruiting patients to investigate if cognitive behavioral therapy (CBT) used on a smartphone or tablet device can reduce anxiety and increase wellbeing in patients with Pulmonary Fibrosis.
Join the studyPatient Brochure.png)
